| Medical Mutual | Fyarro® (sirolimus albumin-bound) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Ixempra® (ixabepilone) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Yondelis® (trabectedin) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Zaltrap® (ziv-aflibercept) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Ziihera® (zanidatamab-hrii) (Intravenous) (EOV) | 2025-09-01 |
| Paramount Healthcare | Vision Therapy | 2025-09-01 |
| Paramount Healthcare | Biomarker and Disease Activity Testing
for Rheumatoid Arthritis | 2025-09-01 |
| Paramount Healthcare | Peroral Endoscopic Myotomy (POEM) | 2025-09-01 |
| Paramount Healthcare | Cardiovascular Disease (CVD) Risk Testing | 2025-09-01 |
| Paramount Healthcare | Genetic and Biomarker Testing for
Alzheimer Disease | 2025-09-01 |